Literature DB >> 8797883

Replication of hepatitis C virus in cultured non-neoplastic human hepatocytes.

N Kato1, M Ikeda, T Mizutani, K Sugiyama, M Noguchi, S Hirohashi, K Shimotohno.   

Abstract

We established a replication system for hepatitis C virus (HCV) using the PH5CH non-neoplastic human hepatocyte line that had been immortalized with simian virus 40 large T antigen. In cells inoculated with sera derived from two HCV-positive blood donors, positive-stranded HCV RNA was detected up to 30 days postinoculation (p.i.). Semi-quantitative analysis of HCV RNA revealed that HCV multiplied during the period of culture. Sequence analysis of the HCV hypervariable region 1 (HVR1) in both cases indicated that HVR1 populations from the cells at 8 days p.i. were apparently different from those of the original inocula. HVR1 populations in infected cells became homogeneous or just a few species were selected over time. These results suggest that HCV is replicating in the human hepatocyte PH5CH cells. This culture system will be useful for detailed studies of the biological effects of HCV in human hepatocytes.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8797883      PMCID: PMC5921176          DOI: 10.1111/j.1349-7006.1996.tb02101.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  24 in total

Review 1.  Molecular biology of the hepatitis C viruses: implications for diagnosis, development and control of viral disease.

Authors:  M Houghton; A Weiner; J Han; G Kuo; Q L Choo
Journal:  Hepatology       Date:  1991-08       Impact factor: 17.425

2.  Sequence diversity of hepatitis C viral genomes.

Authors:  N Kato; M Hijikata; Y Ootsuyama; M Nakagawa; S Ohkoshi; K Shimotohno
Journal:  Mol Biol Med       Date:  1990-12

3.  Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis.

Authors:  N Kato; M Hijikata; Y Ootsuyama; M Nakagawa; S Ohkoshi; T Sugimura; K Shimotohno
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

4.  A structural protein of hepatitis C virus expressed in E. coli facilitates accurate detection of hepatitis C virus.

Authors:  K Muraiso; M Hijikata; S Ohkoshi; M J Cho; M Kikuchi; N Kato; K Shimotohno
Journal:  Biochem Biophys Res Commun       Date:  1990-10-30       Impact factor: 3.575

5.  Humoral immune response to hypervariable region 1 of the putative envelope glycoprotein (gp70) of hepatitis C virus.

Authors:  N Kato; H Sekiya; Y Ootsuyama; T Nakazawa; M Hijikata; S Ohkoshi; K Shimotohno
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

6.  Demonstration of in vitro infection of chimpanzee hepatocytes with hepatitis C virus using strand-specific RT/PCR.

Authors:  R E Lanford; C Sureau; J R Jacob; R White; T R Fuerst
Journal:  Virology       Date:  1994-08-01       Impact factor: 3.616

7.  Susceptibility of human T-lymphotropic virus type I infected cell line MT-2 to hepatitis C virus infection.

Authors:  N Kato; T Nakazawa; T Mizutani; K Shimotohno
Journal:  Biochem Biophys Res Commun       Date:  1995-01-26       Impact factor: 3.575

8.  Specific detection of positive and negative stranded hepatitis C viral RNA using chemical RNA modification.

Authors:  T Gunji; N Kato; M Hijikata; K Hayashi; S Saitoh; K Shimotohno
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

9.  Antibodies in human sera specific to hypervariable region 1 of hepatitis C virus can block viral attachment.

Authors:  A Zibert; E Schreier; M Roggendorf
Journal:  Virology       Date:  1995-04-20       Impact factor: 3.616

10.  Inhibition of hepatitis C virus replication by antisense oligonucleotide in culture cells.

Authors:  T Mizutani; N Kato; M Hirota; K Sugiyama; A Murakami; K Shimotohno
Journal:  Biochem Biophys Res Commun       Date:  1995-07-26       Impact factor: 3.575

View more
  15 in total

1.  Caspase-mediated cleavage of eukaryotic translation initiation factor subunit 2alpha.

Authors:  S Satoh; M Hijikata; H Handa; K Shimotohno
Journal:  Biochem J       Date:  1999-08-15       Impact factor: 3.857

2.  Specific interaction of polypyrimidine tract-binding protein with the extreme 3'-terminal structure of the hepatitis C virus genome, the 3'X.

Authors:  K Tsuchihara; T Tanaka; M Hijikata; S Kuge; H Toyoda; A Nomoto; N Yamamoto; K Shimotohno
Journal:  J Virol       Date:  1997-09       Impact factor: 5.103

3.  Cell cycle progression or translation control is not essential for vesicular stomatitis virus oncolysis of hepatocellular carcinoma.

Authors:  Sabrina Marozin; Enrico N De Toni; Antonia Rizzani; Jennifer Altomonte; Alexandra Junger; Günter Schneider; Wolfgang E Thasler; Nobuyuki Kato; Roland M Schmid; Oliver Ebert
Journal:  PLoS One       Date:  2010-06-07       Impact factor: 3.240

4.  Subgenomic HCV RNA replication and its localization in the nucleus of the infected cells.

Authors:  Zaki Monawar Eisa
Journal:  Saudi J Biol Sci       Date:  2011-02-03       Impact factor: 4.219

5.  Immortalized Human Hepatic Cell Lines for In Vitro Testing and Research Purposes.

Authors:  Eva Ramboer; Tamara Vanhaecke; Vera Rogiers; Mathieu Vinken
Journal:  Methods Mol Biol       Date:  2015

6.  Class A scavenger receptor 1 (MSR1) restricts hepatitis C virus replication by mediating toll-like receptor 3 recognition of viral RNAs produced in neighboring cells.

Authors:  Hiromichi Dansako; Daisuke Yamane; Christoph Welsch; David R McGivern; Fengyu Hu; Nobuyuki Kato; Stanley M Lemon
Journal:  PLoS Pathog       Date:  2013-05-23       Impact factor: 6.823

7.  In-vitro model systems to study Hepatitis C Virus.

Authors:  Usman Ali Ashfaq; Shaheen N Khan; Zafar Nawaz; Sheikh Riazuddin
Journal:  Genet Vaccines Ther       Date:  2011-04-06

Review 8.  Advancement in the development of models for hepatitis C research.

Authors:  Wendy C Carcamo; Cuong Q Nguyen
Journal:  J Biomed Biotechnol       Date:  2012-05-30

9.  Viral Load Analysis of Hepatitis C Virus in Huh7.5 Cell Culture System.

Authors:  Roghayeh Teimourpour; Zahra Meshkat; Aida Gholoubi; Hosein Nomani; Sina Rostami
Journal:  Jundishapur J Microbiol       Date:  2015-05-31       Impact factor: 0.747

10.  Antiviral Profile of Brown and Red Seaweed Polysaccharides Against Hepatitis C Virus.

Authors:  Saly F Gheda; Hala I El-Adawi; Nehal M El-Deeb
Journal:  Iran J Pharm Res       Date:  2016       Impact factor: 1.696

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.